The Utility of Metformin in the Management of Metabolic Syndrome Induced by Atypical Antipsychotics
DOI:
https://doi.org/10.46570/utjms-2026-1676Keywords:
antipsychotics, metabolic syndrome, MetforminReferences
Jesus, C., Jesus, I., & Agius, M. (2015). A review of the evidence for the use of Metformin in the treatment of metabolic syndrome caused by antipsychotics. Psychiatria Danubina, 27 Suppl 1, S489–S491.
Rojo, L. E., Gaspar, P. A., Silva, H., Risco, L., Arena, P., Cubillos-Robles, K., & Jara, B. (2015). Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology. Pharmacological research, 101, 74–85. https://doi.org/10.1016/j.phrs.2015.07.022
Akinola, P. S., Tardif, I., & Leclerc, J. (2023). Antipsychotic-Induced Metabolic Syndrome: A Review. Metabolic syndrome and related disorders, 21(6), 294–305. https://doi.org/10.1089/met.2023.0003
Au, E., Panganiban, K. J., Wu, S., Sun, K., Humber, B., Remington, G., Agarwal, S. M., Giacca, A., Pereira, S., & Hahn, M. (2025). Antipsychotic-Induced Dysregulation of Glucose Metabolism Through the Central Nervous System: A Scoping Review of Animal Models. Biological psychiatry. Cognitive neuroscience and neuroimaging, 10(3), 244–257. https://doi.org/10.1016/j.bpsc.2024.10.001
Manta, A., Georganta, A., Roumpou, A., Zoumpourlis, V., Spandidos, D. A., Rizos, E., & Peppa, M. (2025). Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review). Molecular medicine reports, 31(5), 114. https://doi.org/10.3892/mmr.2025.13479
Wu, R. R., Zhao, J. P., Guo, X. F., He, Y. Q., Fang, M. S., Guo, W. B., Chen, J. D., & Li, L. H. (2008). Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. The American journal of psychiatry, 165(3), 352–358. https://doi.org/10.1176/appi.ajp.2007.07010079
Yu, O., Lu, M., Lai, T. K. Y., Hahn, M., Agarwal, S. M., O'Donoghue, B., Ebdrup, B. H., & Siskind, D. (2024). Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology, 14, 20451253241255476. https://doi.org/10.1177/20451253241255476
de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R. (2016). Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC psychiatry, 16(1), 341. https://doi.org/10.1186/s12888-016-1049-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sweta Desai, Fatimah Aftab, Sara Razoky (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
